Christine Tauras
About Christine Tauras
Christine Tauras is a Senior Manager of Planning and Execution at Bristol Myers Squibb, with a background in biotechnology and oncology clinical research.
Current Role at Bristol Myers Squibb
Christine Tauras currently holds the position of Senior Manager - Planning and Execution at Bristol Myers Squibb in Cambridge, MA. She has been with the company since November 2018. In her role, she works in the Next Generation Diagnostics Group, with a focus on Oncology. She is responsible for planning and executing various initiatives aimed at advancing diagnostic technologies.
Previous Experience at Novartis Institutes for BioMedical Research (NIBR)
From 2013 to 2018, Christine Tauras worked as a Scientist II - Production Manager at Novartis Institutes for BioMedical Research (NIBR) in Cambridge, Massachusetts. During her five-year tenure, she managed production processes and contributed to the development and implementation of laboratory automation and process improvements within the pharmaceuticals industry.
Educational Background
Christine Tauras has a substantial academic background. She earned a Bachelor of Science (B.S.) in Biology from the University of Massachusetts Amherst from 2005 to 2009. She furthered her education by achieving a Master of Science (M.S.) in Biotechnology - Process Development from Northeastern University between 2012 and 2016. Additionally, she completed the HMX Fundamentals - Immunology program at Harvard Medical School in 2020.
Expertise in Laboratory Automation and Process Improvement
Christine Tauras is known for her expertise in Laboratory Automation and Process Improvement, particularly within the pharmaceuticals industry. Her extensive experience includes working with DNA and RNA Sequencing technologies. Her contributions have been pivotal in advancing laboratory efficiency and developing innovative solutions for oncology clinical research.
Early Career at Genzyme Genetics
Christine Tauras began her career at Genzyme Genetics as a Molecular Genetics Technologist I, where she worked from 2009 to 2013 in Westborough, MA. During her four-year tenure, she honed her skills in molecular genetics, setting the foundation for her later roles in the biotechnology and pharmaceutical industries.